医药企业

  • 网络pharmaceutical enterprises
医药企业医药企业
  1. 医药企业建立Internet网站之初探

    How to Establish Web Site for Pharmaceutical Enterprises in Internet

  2. 前言:目的:阐述加入世界贸易组织(WTO)后我国医药企业面临的挑战与对策。

    OBJECTIVE : To describe the challenge to Chinas pharmaceutical enterprises after WTO entry and the countermeasure .

  3. 成长型医药企业实施ERP的风险控制研究

    A Study on Risk Control in ERP Implementation of Growth-type Pharmaceutical Enterprise

  4. 在此基础上,利用实物期权理论建立了RD投资项目决策中实物期权定价模型,并运用以上模型对一医药企业的RD投资项目决策进行了分析研究。

    Furthermore , a pricing model for R & D item is build based on real option theory .

  5. 本文运用需求资源的理论观点,分析了跨国医药企业在中国设立RD机构的投资动机。

    The paper analyzes the motivation of foreign-founded R & D institute in China with the need-resource theory .

  6. 加入WTO,会在某些方面为我国医药业带来一定的发展机遇,但也必须将会使我国医药企业面临严峻挑战。

    Joining WTO brings us not only opportunities in development , but also great challenges to our medical enterprises .

  7. 对于加入WTO后面临更为激烈市场竞争环境的医药企业,更为迫切需要电子商务推动企业的发展。

    Regarding joins behind WTO near the more intense market competition environment medicine enterprise , more urgent need electronic commerce impetus enterprise 's development .

  8. 浅谈医药企业的DTC营销模式

    Analysis of the Mechanism of Pharmaceutical Enterprises ' DTC Marketing Mode

  9. 浅谈医药企业贯彻实施ISO9000标准

    How to implement ISO 9000 Series Standards in medical Enterprises

  10. CSI工程:医药企业营销竞争的新要素

    CSI : New Factor for Marketing Competition of Pharmaceutical Enterprises

  11. 医药企业通过GMP认证的体会

    Experiences of Acquisition of GMP Authentication for Pharmaceutical Enterprises

  12. 该文章首先分析了我国加入WTO以后医药企业面临的挑战和机遇并提出应对措施;

    This article first analyzes the challenges and opportunities facing China 's pharmaceutical industry after China 's entry into Wto , and propose the responsive measures ;

  13. 论文介绍了医药企业形象和CIS的定义和内容。

    The thesis gives the definitions and contents of the medical enterprise image and the CIS .

  14. 从1995年到2005年10年中,我国的医药企业不断壮大,整个医药产业在GDP中的比重翻了两番,达到了4%。

    From 1995 to 2005 , China 10 years and pharmaceutical enterprise expands unceasingly , the whole medicine industry weight in GDP tripled to reach 4 % .

  15. 医药企业eCRM构建

    The eCRM of Pharmaceutical Enterprises

  16. 结果:DTC营销处于不断发展之中,且医药企业对其兴趣有增无减,但尚需进一步规范和完善。

    RESULTS : Drug DTC marketing was under development in the world and pharmaceutical enterprises hawe showed increasing interest in it , however , drug DTC marketing needed further standardization and improvement .

  17. 本研究从医药企业污水处理池的活性污泥中分离得到一株能以二甲基甲酰胺(DMF)为唯一碳、氮源生长的菌株。

    A bacterial strain , capable of utilizing DMF ( N , N-dimethylformamide ) as sole carbon and nitrogen source was isolated from activated sludge collected from wastewater-treating system of a pharmaceutical enterprise .

  18. 加入WTO后,发达国家药品知识产权保护将更加严格,我国医药企业只有依靠科技兴药,同时充分利用国际资源和国际市场才会有出路。

    The developed country drugs intellectual property rights protection will be stricter after we take part in to WTO , our medicine enterprises will only have the dependence on science and technology to make medicines , and use the international resources and the international market then can have the outlet .

  19. 如何打破瓶颈,找到属于自己的那片蓝海不单单是BHF公司想要解决的问题,也是诸多国内医药企业想要解决的问题。

    How to break the bottlenecks , and found to the blue sea , not only BHF company wants to solve the problem is also a number of domestic companies want to solve the problem .

  20. 特别是我国医疗保险体制进行了重大改革,实施了医、药分家和药品分类管理制度。一个全新的、规范的药品市场&非处方药(OTC)市场出现在广大医药企业面前。

    Especially after the strategic reform of healthcare issuance system and implementing the division of " medical " and " medicine " and classification management of medicine , a giant , new and regulated market for OTC is generated for medicine enterprises .

  21. 我国医药企业营销渠道成员冲突原因及其对策研究

    Causes and Solutions for Channel Conflicts in Pharmaceutical Distribution in China

  22. 对医药企业来说,它既是机遇也是挑战。

    For pharmaceutical companies , it is both opportunity and challenge .

  23. 医药企业农村市场开发问题研究

    The Research on the Development of Rural Market by Medicine Companies

  24. 销售人员的流失率居高不下给医药企业带来巨大压力。

    High sales ' turnover rate leads great pressure to pharmaceutical companies .

  25. 我国医药企业发展战略选择

    The Developing Strategy Selection of the Medicine Corporation in China

  26. 我国生物医药企业的现状与展望

    Current Status and Expectation of the Biopharmaceutical Industry in China

  27. 医药企业如何制定并实施关系营销战略的问题。

    How to constitute and implement relationship marketing strategies concerned .

  28. 医药企业关系营销战略案例分析与研究

    A Case Analysis & Study of Relationship Marketing Strategy in Medicinal Enterprises

  29. 我国医药企业知识产权管理研究

    Study on Intellectual Property Management of Pharmaceutical Enterprises in China

  30. 我国医药企业人才国际化对策探讨

    Study on the Strategy of Talents Internationalization of Pharmaceutical Enterprises in China